A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway [version 1; peer review: 2 approved]
Background: Both oxytocin and carbetocin are used to prevent uterine atony and post-partum haemorrhage after caesarean delivery in many countries, including Norway. Oxytocin causes dose-dependent ST-depression, troponin release, prolongation of QT-time and arrythmia, but little is known about myocar...
Saved in:
Main Authors: | Maria Bekkenes, Marte Morin Jørgensen, Anne Flem Jacobsen, Morten Wang Fagerland, Helene Rakstad-Larsen, Ole Geir Solberg, Lars Aaberge, Olav Klingenberg, Trude Steinsvik, Leiv Arne Rosseland |
---|---|
Format: | article |
Language: | EN |
Published: |
F1000 Research Ltd
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b8a79d929e3149e093132bb3a3af4a80 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF ORAL (20 µG 2 HOURLY) VERSUS VAGINAL (25 µG 6 HOURLY) MISOPROSTOL FOR INDUCTION OF LABOUR IN TERM PREGNANCIES
by: Tahmina Yousaf, et al.
Published: (2019) -
Carbetocin versus Rectal Misoprostol to Decrease Blood Loss in Vaginal Delivery in High Risk Patients for Postpartum Hemorrhage
by: Yasmin Abd-Elmoaty Abdo Mohamed Hetiba, et al.
Published: (2021) -
Route of oxytocin administration for preventing blood loss at caesarean section: a systematic review with meta-analysis
by: Ana Pilar Betran, et al.
Published: (2021) -
A COMPARISON OF COMPLICATIONS IN PREVIOUS CAESAREAN WITH NON CAESAREAN CASES UNDERGOING MISOPROSTOL INDUCED MID TRIMESTER ABORTIONS
by: Bushra Iktikhar, et al.
Published: (2019) -
Reversibilidad espirométrica en pacientes con enfermedad pulmonar obstructiva crónica: ¿Debe emplearse 200 ó 400 µg de salbutamol?
by: Manríquez,Jorge, et al.
Published: (2006)